Safety assessment of personal care products/cosmetics and their ingredients

Toxicology and Applied Pharmacology

Volumn 243, Issue 2, 2010, Pages 239-259

  Nohynek, Gerhard J ^a   Antignac, Eric ^a   Re, Thomas ^b   Toutain, Herve ^a  

^a Global Safety Evaluation   (France)

^b Research and Development   (United States)

Author keywords

Cosmetic ingredients; Hair dyes; Nanoparticles; Personal care products; Safety assessment; Threshold of toxicological concern; Ultraviolet filters

Indexed keywords

COSMETIC; HAIR DYE; SUNSCREEN;

ANIMAL; CHEMISTRY; DRUG LEGISLATION; HUMAN; METHODOLOGY; PLANT; REVIEW; RISK ASSESSMENT; SAFETY;

ANIMALS; CONSUMER PRODUCT SAFETY; COSMETICS; HAIR DYES; HUMANS; LEGISLATION, DRUG; PLANTS; RISK ASSESSMENT; SAFETY; SUNSCREENING AGENTS;

EID: 77949365784     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2009.12.001     Document Type: Article

References (187)

1. Aeby, P., Sie ber, T., Beck, H., Gerberick, F.G., Goebel, C., Skin sensitization to p-phenylenediamine: the diverging roles of oxidation and N-acetylation for dendritic cell activation and the immune response. J. Invest. Dermatol. 129 (2009), 99–109.
2. Allemann, I.B., Baumann, L., Botanicals in skin care products. Internat. J. Dermatol. 48 (2009), 923–934.
3. Ames, B.N., Kammen, H.O., Yamasaki, E., Hair dyes are mutagenic: Identification of a Variety of Mutagenic Ingredients. Proc. Natl. Acad. Sci. U.S.A. 72:6 (1975), 2423–2427.
4. Ashby, J., Tennant, R.W., Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the US NTP. Mut. Res. 257 (1991), 229–306.
5. Axmon, A, Rylander, L., Birth weight and fetal growth in infants born to female hairdressers and their sisters. Occup. Environ. Med. 66:3 (2009), 198–204.
6. Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Cogliano, V., Carcinogenicity of some aromatic amines, organic dyes and related exposures. Lancet Oncol. 9 (2008), 322–323.
7. Babish, J.G., Scarlett, J.M., Voekler, S., Gutemann, W.H., Lisk, D.J., Urinary mutagens in cosmetologists and dental personnel. J. Toxicol. Environ. Health 34 (1991), 197–206.
8. Bando, H., Mohri, S., Y amashita, F., Takakura, Y., Hashida, M., Effects of skin metabolism on percutaneous penetration of lipophilic drugs. J. Pharmaceut. Sci. 86:9 (1997), 759–761.
9. Barlow, S.M., Greig, J.B., Bridges, J.W., Carere, A., Carpy, A.J.M., Galli, C.L., Kleiner, J., Knudsen, I., Koëter, H.B.V.M., Levy, L.S., Madsen, C., Mayer, S., Narbonne, J.F., Pfannkuch, F., Prodanchuk, M.G., Smith, M.R., Steinberg, P., Hazard identification by methods of animal-based toxicology. Food Chem. Toxicol. 40:2002 (2002), 145–191.
10. Bach-Thomsen, M, Wulf, H.C., Sunbather's application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol. Photoimmunol. Photomed. 9 (1993), 242–244.
11. Benech-Kieffer, F., Meuling, W.J.A., Leclerc, C., Roza, L., Leclaire, J., Nohynek, G., Percutaneous absorption of Mexoryl SX® in human volunteers: comparison with in vitro data. Skin Pharmacol. Appl. Skin Physiol. 16 (2003), 343–355.
12. Benning, V., Brault, D., Duvinage, C., Thybaud, V., Melcion, C., Validation of the in vivo CD1 Mouse Splenocyte Micronucleus Test. Mutagenesis 9:3 (1994), 199–204.
13. BfR (2009). Federal Institute for Risk Assessment, Berlin, Germany, 15 October, 2009. Summary published at the BfR web site: http://www.bfr.bund.de/cd/31861.
14. Bolt, H.M., Golka, K., The debate on carcinogenicity of permanent hair dyes: new insights. Crit. Rev. Toxicol. 37 (2007), 521–536.
15. Bos, J.D., Meinardi, M.M.H.M., The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exper. Dermatol. 9 (2000), 165–169.
16. Burnett, C., Lanman, B., Giovacchini, R., Wolcott, G., Scala, Keplinger, M., Long-term toxicity studies on oxidation hair dyes. Food Cosm. Toxicol. 13 (1975), 353–357.
17. Burnett, C., Jacobs, M.M., Seppala, A., Shubik, P., Evaluation of the toxicity and carcinogenicity of hair dyes. J. Toxicol. Environ. Health 6 (1980), 247–257.
18. Burnett, C, Loehr, R, Corbett, J., Heritable translocation study on two hair dye formulations. Fundam. Appl. Toxicol. 1 (1981), 325–328.
19. Burnett, C.M., Corbett, J.F., Failure of short-term in vitro mutagenicity tests to predict the animal carcinogenicity of hair dyes. Food Chem. Toxicol. 25:9 (1987), 703–707.
20. Burnett, C.M., Goldenthal, E.J., Multigeneration reproduction and carcinogenicity studies in Sprague Dawley rats exposed topically to oxidative hair coloring formulations containing p-phenylenediamine. Food Chem. Toxicol. 26 (1988), 467–474.
21. Cantox Inc. (1997). Assessment of the reproductive risks posed to the users of hair dye products containing monoethanolamine, p-aminophenol and o-aminophenol. Cantox Inc., Mississauga, Ontario, Canada, September 10, 1997 (unpublished).
22. CCC, Consumer Commitment Code (2008). Available at: http://www.personalcarecouncil.org/Content/NavigationMenu/About_Us/Consumer_Commitment_Code1/Consumer_Commitment_Code.htm.
23. Choi, M.J., Maibach, H.I., Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol. Physiol. 18 (2005), 209–219.
24. CIR (2007). The Cosmetic Ingredient Review. Available at: http://www.cir-safety.org/.
25. CIR. Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben and benzylparaben as used in cosmetic products. Intern. J. Toxicol. 27:Suppl. 4 (2008), 1–82.
26. Colditz, G.A., Coakley, E., Weight, weight gain, activity, and major illnesses: the Nurse's Health Study. Int. J. Sports Med. 18:Suppl. 3 (1997), 162–170.
27. Constable, A., Jonas, D., Cockburn, A., Davi, A., Edwards, G., Hepburn, P., Herouet-Guicheney, C., Knowles, M., Moseley, B., Oberdorfer, R., Samuels, F., History of safe use as applied to the safety assessment of novel foods and foods derived from genetically modified organisms. Food Chem. Toxicol. 45 (2007), 2513–2525.
28. Corbett, J.E., Sharma, R.K., Dressler, W.E., Cosmetic toxicology. Marquardt, H., Schäfer, S.G., McClellan, R.O., Welsch, F., (eds.) Toxicology, 1999, Academic Press, San Diego, CA, USA, 899–918 Chapter 30.
29. Cordle, F., Thompson, G.E., An epidemiologic assessment of hair dye use. Reg. Toxicol. Pharmacol. 1 (1981), 388–400.
30. Cramer, G.M., Ford, R.A., Hall, R.L., Estimation of toxic hazard—decision tree approach. Food Cosm. Toxicol. 16:3 (1978), 255–276.
31. Czene, K., Tiikaja, S., Hemminki, K, Cancer risks in hairdressers: assessment of carcinogenicity of hair dyes and gels. Int. J. Cancer 105 (2003), 108–112.
32. DeGroot, A.C., Fatal attractiveness: the shady side of cosmetics. Clin. Dermatol. 16 (1998), 167–179.
33. DeLeo, V., P-phenylenediamine. Dermatitis 17:2 (2006), 53–55.
34. Draize, J.H., Methods for study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J. Pharmacol. Experim. Therapeutics 82 (1944), 377–390.
35. Dressler, W.E., Appelqvist, T., Plasma/blood pharmacokinetics after dermal exposure to para-aminophenol or para-phenylenediamine. Food Chem. Toxicol. 44 (2006), 371–379.
36. Dufour, E.K., Kumaravel, T, Nohynek, G.J., Kirkland, D., Toutain, H., Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity? Genotoxic effects of ZnO in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mut. Res. 607 (2006), 215–224.
37. EC (1997a). Regulation (EC) No. 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. Official Journal of the European Communities, L 43/1-7, 14 February 1997.
38. EC (1997b). Commission Recommendation 97/618/EC of 29 July 1997 concerning the scientific aspects and the presentation of information necessary to support applications for the placing on the market of novel foods and novel food ingredients and the preparation of initial assessment reports under Regulation (EC) No. 258/97 of the European Parliament and of the Council. Official Journal of the European Communities, L 253/1-36, 16 September 1997.
39. Edwards, G., Safety assessment of novel foods and strategies to determine their safety in use. Toxicol. Applied Pharmacol. 207 (2005), S623–S627.
40. EFSA, (2004). Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food, 2004. Opinion on Flavouring Group FGE.03 Acetals of branched- and straight-chain aliphatic saturated primary alcohols and branched- and straight-chain saturated aldehydes, and an orthoester of formic acid, from chemical groups 1 and 2. Opinion expressed on 7 October 2004.
41. EFSA Scientific Committee. Guidance on safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements. EFSA Journal, 7(9), 2009, 1249.
42. Eisenbrand, G., Pool-Zobel, B., Baker, V., Balls, M., Blaauboer, B.J., Boobis, A., Carere, A., Kevekordes, S., Lhugenot, J.C., Pieters, R., Kleiner, J., Methods of in vitro toxicology. Food. Chem. Toxicol. 40 (2002), 193–236.
43. El Maghraby, G.M., Barry, B.W., Williams, A.C., Liposomes and skin: from drug delivery to model membranes. Eur. J. Pharm. Sci. 34:4-5 (2008), 203–222.
44. Ernst, E., The risk-benefit profile of commonly used herbal therapies: Ginkgo, St John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Annals of Internal Medicines 136 (2002), 42–53.
45. EU (2007). Council Directive of July 27, 1976 on the approximation of the laws of the Member States. relating to cosmetic products. 76/768/EEC. At: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:1976L0768:20070508:EN:PDF.
46. EMEA (2005). European Medicines Agency. Committee on herbal medicinal products. Public statement on the risks associated with the use of herbal products containing aristolochia species. EMEA/HMPC/138381/2005.
47. EMEA (2006). European Medicines Agency. Committee on herbal medicinal products. Guideline on non-clinical documentation for herbal medicinal products in application for marketing authorisation (bibliographical and mixed applications) and in applications for simplified registration. EMEA/HMPC/32116/2005.
48. EMEA (2008). European Medicines Agency. Committee on herbal medicinal products. Draft assessment report on Hypericum perforatum L., herba. EMEA/HMPC/101303/2008 Corr.
49. Fabian, E., Landsiedel, R., Ma-Hock, L., Wiench, K., Wohlleben, W., Ravenszwaay, B., Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 82:3 (2008), 151–157.
50. Federal Food, Drug and Cosmetic Act (2004). US Food and Drug Administration. Available at: http://www.fda.gov/opacom/laws/fdcact/fdctoc.htm.
51. Filipe, P., Silva, J.P., Silva, R., Cirne de Castro, J.L., Marques Gomes, M., Alves, L.C, Santus, R., Pinheiro, T., Stratum corneum is an effective barrier to TiO2 and ZnO nanoparticle percutaneous absorption. Skin Pharmacol. Physiol. 22 (2009), 266–275.
52. FDA (2004). Food and Drug Administration. 21 CFR Part 119. February 11, 2004. Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Final Rule. Fed. Reg., Volume 69, Number 28, Page 6787-6854.
53. Food and Drug Administration (2004). Guidance for industry on botanical drug products. Center for Drug Evaluation and Research (CDER).At: http://www.fda.gov/.
54. Frawley, J.P., Scientific evidence and common sense as a basis for food-packaging regulations. Food Cosmet. Toxicol. 5 (1967), 293–308.
55. Freudenthal, R.I., Stephens, E., Anderson, D.P., Determining the potential of aromatic amines to induce cancer of the urinary bladder. Intern. J. Toxicol. 18 (1999), 353–359.
56. Fu, P.P., Chiang, H.M., Xia, Q., Chen, T., Chen, B.H., Yin, J.J., Wen, K.C., Lin, G., Lin, G., Yu, H., Quality assurance and safety of herbal dietary supplements. J. Environ. Science Health, part C 27 (2009), 91–119.
57. Gago-Dominguez, M., Castelao, J.E., Yuan, J.M., Yu, M.C., Ross, R.K., Use of permanent hair dyes and bladder cancer risk. Int. J. Cancer 91 (2001), 575–579.
58. Gago-Dominguez, M., Bell, D.A., Watson, M.A., Jian-Min, Y., Castelao, J.E., Hein, D.W., Chan, K.K., Coetzee, G.A., Ross, R.K., Yu, M.C., Permanent hair dyes and bladder cancer: risk modification by cytochrome P450A2 and N-acetyltransferase 1 and 2. Carcinogenesis 24:3 (2003), 483–489.
59. Gallicchio, L., Miller, S., Greene, T., Zacur, H., Flaws, J.A., Cosmetologists and reproductive outcomes. Obstet. Gynecol. 113:5 (2009), 1018–1025.
60. Garrigue, J.L., Ballantyne, M., Kumaravel, T., Lloyd, M., Nohynek, G.J., Kirkland, D., Toutain, H., In vitro genotoxicity of para-phenylenediamine and its N-monoacetyl and N,N'-diacetyl metabolites. Mut. Res. 608 (2006), 58–71.
61. Goebel, C., Sieber, T., Göttel, O., Chassot, L., Gerberick, F., Aeby, P., N-acetylation of aromatic amines antagonizes haptenization. Toxicol. Lett., 172S, 2007, S31.
62. Gold, L.S., Manley, N.B., Ames, B.N., Extrapolation of carcinogenicity between species: qualitative and quantitative factors. Risk Analysis 12:4 (1992), 579–588.
63. Golka, K., Prior, V., Blaszkewicz, M., Bolt, H.M., The enhanced bladder cancer susceptibility of NATY2 slow acetylators towards aromatic amines: a review considering ethnic differences. Toxicol. Lett. 128 (2002), 229–241.
64. Goossens, A., Merckx, L., L'allergie de contact aux cosmetiques. Allergie et Immunologie 24:10 (1997), 300–303.
65. Gopee, N.V., Roberts, D.W., Webb, P., Cozart, C.R., Siitonen, P.H., Warbritton, A.R., Yu, W.W., Colvin, V.L., Walker, N.J., Howard, P.C., Migration of intradermally injected quantum dots to sentinel organs in mice. Toxicol. Sci. 98:1 (2007), 249–257.
66. Goulet, L., Thériault, G., Stillbirth and chemical exposure of pregnant workers. Scand. J. Work Environ. Health 17 (1991), 25–31.
67. Halliday-Bell, J, Gissler, M, Jaakola, JK., Work as hairdresser and cosmetologist and adverse pregnancy outcomes. Occup. Med. 59 (2009), 180–184.
68. Hartung, T., Toxicology for the twenty-first century. Nature 460 (2009), 208–212.
69. Herdt-Losavio, ML, Lin, S, Druschel, CM, Hwang, SA, Mauer, MP, Carlson, GA., The risk of having a low birth weight or preterm infant among cosmetologists in New York Sate. Matern. Child Health J. 13 (2009), 90–97.
70. Horio, T., The induction of photocontact sensitivity in guinea pigs without UVB radiation. J. Invest. Dermatol. 67:5 (1976), 591–593.
71. Hueber-Becker, F., Nohynek, G.J., Meuling, W.A.J., Benech-Kieffer, F., Toutain, H., Human systemic exposure to a [14C]-paraphenylenendiamine-containing oxidative hair dye and correlation of in vitro percutaneous absorption in human and pig skin. Food Chem. Toxicol. 42 (2004), 1227–1236.
72. Hueber-Becker, F., Nohynek, G.J., Dufour, E.K., Meuling, W.J.A., de Bie, A.T.H.J., Toutain, H, Bolt, H.M., Occupational exposure of hairdressers to a [14C]-para-phenylenediamine-containing oxidative hair dyes: a mass balance study. Food Chem. Toxicol. 45 (2007), 160–169.
73. Hueber-Becker, F., Dufour, E.K., Meuling, W.A.J., deBie, A.T.H.J., Toutain, H., Nohynek, G.J., Systemic exposure of women of childbearing age to a [14C]-thioglycolate-containing depilatory product: implications for risk assessment and animal testing. Submitted to Food. Chem. Toxicol., 2009 October 2009.
74. IARC (1993). International Agency for the Research of Cancer, World Health Organisation. Occupational exposure of hairdressers and barbers and personal use of hair colorants. Some hair dyes, cosmetic colorants, industrial dyestuffs and aromatic amines. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Volume 57, World Health Organisation, Geneva, Switzerland.
75. ICH (2009). The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Available at: http://www.ich.org/cache/compo/276-254-1.html.
76. ILSI, (2003). The safety assessment of novel foods and concepts to determine their safety in use. ILSI Europe Report Series.
77. Jacobi, U., Weigmann, H.J., Ulrich, J., Sterry, W., Lademann, J., Estimation of the relative stratum corneum amount removed by tape stripping. Skin Res. Technol. 11:2 (2005), 91–96.
78. JECFA (1998). Safety evaluation of certain food additives and contaminants. In: 49th Meeting of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization (WHO), International Programme on Chemical Safety (IPCS), Geneva, Switzerland, WHO Food Additives Series, No. 40.
79. Jewell, C., Prusakiewic, J.J., Ackermann, C., Payne, A.N., Fate, G., Voorman, R., Williams, F.M., Toxciol. Appl. Pharmacol. 225 (2007), 221–228.
80. Jonas, D.A., Antignac, E., Antoine, J.M., Classen, H.G., Huggett, A., Knudsen, I., Mahler, J., Ockhuizen, T., Smith, M., Teuber, M., Walker, R., De Vogel, P., The safety assessment of novel foods. Food Chem. Toxicol. 34 (1996), 931–940.
81. Kadlubar, F., Hammons, G.J., Guengrich, F.P., (eds.) Mammalian Cytochrom P-450, Vol. 2, 1986, CRC Press, Boca Raton, Fl, US, 81–130.
82. Kawakubo, Y., Merck, H.F., Al Masaoudi, T., Sieben, S., Bloemeke, B., N-acetylation of paraphenylenediamine in human skin and keratinocytes. J. Pharmacol. Exp. Therapeutics 292:1 (2000), 150–155.
83. Kelsh, M.A., Alexander, D.D., Kalmes, R.M., Buffler, P.A., Personal use of hair dyes and risk of bladder cancer: a meta-analysis of epidemiologic data. Cancer Causes Control 19:6 (2008), 549–558.
84. Kersemaekers, W., Roeleveld, N., Zielhus, G., Reproductive disorders due to chemical exposure among hairdressers. Scand. J. Work Environ. Health 21 (1995), 325–334.
85. Kersemaekers, W., Roeleveld, N., Zielhus, G., Reproductive disorders among hairdressers. Epidemiology 8:4 (1997), 396–401.
86. Kirkland, D.J., Lawler, S.D., Venitt, S., Chromosomal damage and hair dyes. Lancet, 1978, 124–128 July 15, 1978.
87. Kirkland, D.J., Honeycombe, J.R., Lawler, S.D., Vernitt, S., Crofton-Sleigh, C., Sister chromatid exchanges before and after hair dyeing. Mut. Res. 90 (1981), 279–286.
88. Kirkland, D.J., Dresp, J.H., Marshall, R.R., Baumeister, M., Gerloff, C., Gocke, E., Normal chromosome aberration frequencies in peripheral lymphocytes of human volunteers exposed to a maximal daily dose of paracetamol in a double blind trial. Mut. Res. 279 (1992), 181–194.
89. ™Mouse can distinguish carcinogenic from non-carcinogenic analogues of diaminotoluenes and nitronaphthalenes. Mut. Res. 608 (2006), 88–96.
90. Kirkland, D., Pfuhler, S., Tweats, D., Aardema, M., et al. How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: report of an ECVAM Workshop. Mut. Res. 628 (2007), 31–55.
91. Kleinhans, D, Knoth, W., Granulomas of the axilla. Dermatologica 152:3 (1976), 161–167.
92. Kogevinas, M, Fernandez, F, Garcia-Closas, M, Tardon, A, Garcia-Closas, R, Serra, C, Carrato, A, Castano-Vinyals, G, Yeager, M, Chanock, SJ, Lloreta, J, Rothman, N, Real, FX, Dosemeci, M, Malats, N, Silverman, D., Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur. J. Cancer 42 (2006), 1448–1454.
93. Krasteva, M., Cottin, M., Cristaudo, A., Laine, G., Nohynek, G., Orton, D., Toutain, H., Severino, V., Wilkinson, J., Sensitivity and specificity of the consumer open skin allergy as a method of prediction of contact dermatitis to hair dyes. Eur. J. Dermatol. 15:1 (2005), 18–25.
94. Krasteva, M., Bons, B., Ryan, C., Gerberick, F.G., Consumer allergy to oxidative hair coloring products: epidemiological data in the literature. Dermatitis 20:3 (2009), 123–141.
95. Krasteva, M., Bons, B., Tozer, S., Rich, K., Hoting, E., Hollenberg, D., Fuchs, A., Fautz, R., Contact allergy to hair colouring products. The cosmetovigilance experience of four companies (2003-2006). Eur. J. Dermatol. 20:1 (2010), 1–11 E-publication.
96. Kroes, R., Walker, R., Safety issues of botanicals and botanical preparations in functional foods. Toxicology 198 (2004), 213–220.
97. Kroes, R., Kleiner, J., Renwick, A., The threshold of toxicological concern concept in risk assessment. Toxicol. Sci. 86 (2005), 226–230.
98. Kroes, R., Renwick, A.G., Feron, V., Galli, C.L., Gibney, M., Greim, H., Guy, R.H., Lhuguenot, J.C., van de Sandt, J.J., Application of the threshold of toxicological concern (TTC) to the safety evaluation of cosmetic ingredients. Food Chem. Toxicol. 45:12 (2007), 2533–2562.
99. Lademann, J., Richter, H., Jacobi, U., Patzelt, A., Hueber-Becker, F., Ribaud, C., Benech-Kieffer, F., Dufour, E., Sterry, W., Schaefer, H., Leclaire, J., Toutain, H., Nohynek, G.J., Human percutaneous absorption of a direct hair dye comparing in vitro and in vivo results: implications for safety assessment and animal testing. Food Chem. Toxicol. 46 (2008), 2214–2223.
100. Lalko, J., Api, A.M., Investigation of the dermal sensitization potential of various essential oils in the local lymph node assay. Food Chem. Toxicol. 44 (2006), 739–746.
101. LaVecchia, C., Tavani, A., Epidemiological evidence on hair dyes and the risk of bladder cancer in humans. Eur. J. Cancer Prevention 4 (1995), 31–43.
102. LaVecchia, C., Airodi, L., Human bladder cancer: epidemiological, pathological and mechanistic aspects. IARC Scientific Publication No. 147, 139-157, 1999, International Agency for Research of Cancer, Lyon, France.
103. LaVecchia, C., Tavani, A., Hair dyes and bladder cancer: an update. Eur. J. Cancer Prevention 10 (2001), 205–208.
104. Lin, J., Dinney, C.P., Grossman, H.B., Wu, X., Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Canc. Epidemiol. Biomarkers 15:9 (2006), 1746–1749.
105. Malkey, J.P., Oehme, F.W., A review of thallium toxicity. Vet. Hum. Toxicol. 35 (1993), 445–453.
106. Marks, T.A., Gumpta, B.N., Ledoux, T.A., Staples, R.E., Teratogenic evaluation of 2-nitro-o-phenylenediamine, 4-nitro-phenylenediamine and 2,5-toluenediaminesulfate in the mouse. Teratology 24 (1981), 253–256.
107. Maouad, M., Fleischer, A.B., Sherertz, E.E., Feldman, S.R., Significance-prevalence index number: a re-interpretation and enhancement of data from the North American Contact Dermatitis Group. J. Am. Academ. Dermatol. 41:4 (1999), 573–576.
108. Marzulli, F.N., Maibach, H.I., Permeability and reactivity of skin related to age. J. Soc. Cosm. Chem. 35 (1984), 95–102.
109. McDonald, A.D., McDonald, J.M.C., Armstrong, B., Cherry, N.M., Nolin, A.D., Rober, D., Prematurity and work in pregnancy. Brit. J. Ind. Med. 45 (1988), 56–62.
110. Mavon, A., Miquel, C., Lejeune, O., Payre, B., Moretto, P., In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol. Physiol. 20 (2007), 10–20.
111. Mendelson, J.B., Qi-Zhai, L., Bu-Tian, J., Shu, X.O., Yang, G., Li, H.L., Lee, K.M., Yu, K., Rothman, N., Gao, Y.T., Zhang, W., Cjow, W.H., Cancer Sci. 100:6 (2009), 1088–1091.
112. 14C]-PPD labelled mass balance study. TNO, Zeist, The Netherlands, Report No. 7852. 1 September, 2009 (unpublished). Publication in preparation.
113. MHLW (2007). Ministry of Health Labor and Welfare, Tokyo, Japan. Quasi drugs. Available at: http://www.mhlw.go.jp/english/links/index.html.
114. Ministry of Health, Pejing, People's Republic of China (2009): Review and approval procedures for health related products. Pre-marketing approval cosmetics. Available at: http://www.chinafdc-law.com/ or http://www.sda.gov.cn/WS01/CL0055/40731.html.
115. Munro, I.C., Ford, R.A., Kennepohl, E., Sprenger, J.G., Correlation of structural class with no-observed-effect levels: a proposal for establishing a threshold of concern. Food Chem. Toxicol. 34:9 (1996), 829–867.
116. Munro, I.C., Kennepohl, E., Comparison of estimated daily per capita intakes of flavouring substances with no-observed-effect levels from animal studies. Food Chem. Toxicol. 39 (2001), 331–354.
117. Munro, I.C., Danielewska-Nikiel, B., Comparison of estimated daily intakes of flavouring substances with no-observed-effect levels. Food Chem. Toxicol. 44 (2006), 758–809.
118. Munro, I.C., Renwick, A.G., Danielewska-Nikiel, B., The Threshold of Toxicological Concern (TTC) in risk assessment. Toxicol. Lett. 180 (2008), 151–156.
119. Neal, R.A., Doull, J., The discipline of toxicology. Fund. Appl. Toxicol. 24 (1995), 151–153.
120. Nohynek, G.J., Schaefer, H., Risk and benefit of organic ultraviolet filters. Reg. Toxicol. Pharmacol. 33 (2001), 285–299.
121. Nohynek, G.J., Fautz, R., Benech-Kiefer, F., Toutain, H., Safety and human health risk of hair dyes. Food Chem. Toxicol. 42 (2004), 517–543.
122. Nohynek, G.J., Skare, J.A., Meuling, W.JA., Hein, D.W., deBie, A.T.H.J., Toutain, H., Urinary acetylated metabolites and N-acetyltransferase-2 genotype in human subjects treated with a para-phenylenediamine-containing oxidative hair dye. Food Chem. Toxicol. 42 (2004), 1885–1891.
123. Nohynek, G.J., Kirkland, D., Marzin, D., Toutain, H., Leclerc-Ribaud, C., Jinnai, H., An assessment of the genotoxicity and human health risk of topical use of kojic acid [5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one]. Food Chem. Toxicol. 42 (2004), 93–105.
124. Nohynek, G.J., Duche, D., Garrigue, A., Meunier, P.A., Toutain, H., Leclaire, J., Under the skin: biotransformation of para-aminophenol and para-phenylenediamine in reconstructed human skin and human hepatocytes. Toxicol. Lett. 158 (2005), 196–212.
125. Nohynek, G.J., Meuling, W.J.A., Vaes, W.J.H., Lawrence, R.S., Shapiro, S., Schulte, S., Steiling, W., Bausch, J., Gerber, E, Sasa, H., Nau, H., Repeated topical treatment, in contrast to single oral doses, with vitamin A-containing preparations does not affect plasma concentrations of retinol, retinyl esters or retinoic acids in female volunteers of child-bearing age. Toxicol. Lett. 63 (2006), 65–76.
126. Nohynek, G.J., Lademann, J., Ribaud, C., Roberts, M.S., Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit. Rev. Toxicol. 37 (2007), 251–277.
127. Nohynek, G.J., Dufour, E.K., Roberts, M.S., Nanotechnology, cosmetics and the skin: is there a health risk. Skin Pharmacol. Physiol. 21 (2008), 136–149.
128. Nortier, J.L., Muniz Martinez, M.-C., Schmeiser, H.H., Arlt, V.M., Bieler, C.A., Petein, M., Depierreux, M.F., De Paw, L., Abramowicz, D., Vereerstraeten, P., Vanherwegheim, J.L., Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fanghi). New Eng. J. Med. 342:23 (2000), 1686–1692.
129. NTP (1978). US National Toxicology Program. Bioassay of 2,4-Diaminoanisole Sulfate for Possible Carcinogenicity, NTP Report TR-84.
130. NTP (2008). National Toxicology Program. Aristolochic acids. Reports on carcinogens. Fed. Register Vol. 73, 84, April 30, 2008.
131. OECD, 2007. Guidance on Grouping of Chemicals (no. 80). ENV/JM/MONO(2007)28.
132. PAP (2005). 1-Hydroxy-4-aminobenzene. Published and unpublished studies contained in the industry submission IV to the EU SCCNFP. Reviewed in the EU SCCP Opinion of 15 March, 2005. Available at: http://ec.europa.eu/health/ph_risk/committees/04_sccp/.
133. Pauwels, M., Rogiers, V., Safety evaluation of cosmetics in the EU: reality and challenges for the toxicologist. Toxicol. Lett. 151:1 (2004), 7–17.
134. Pauwels, M., Dejaegher, B., Heyden, Y.V., Rogiers, V., Critical analysis of the SCCNFP/SCCP safety assessment of cosmetic ingredients (2000–2006). Food Chem. Toxicol. 47 (2009), 898–905.
135. Pepelko, W.E., Withey, J.R., Methods for route-to-route extrapolation of dose. Toxicol. Ind. Health 1:4 (1985), 153–170.
136. Pinheiro, T., Allon, J., Alves, L.C., Filipe, P., Silva, J.N., The influence of corneocyte structure on the interpretation of permeation profiles of nanoparticles across the skin. Nuclear Instrum Methods Phys. Res. B 260 (2007), 119–123.
137. Prentice, D. (2002). Preclinical Safety Consultants, Ettingen, Switzerland, personal communication, April 2002.
138. Preston, R.J., Skare, J.A., Aardema, M.J. (2009). A review of biomonitoring studies measuring genotoxicity in humans exposed to hair dyes. Mutagenesis Elelectr. advance access: doi: 10.1093/mutage/gep044.
139. Prusakiewic, J.J., Ackermann, C., Vorrman, R., Comparison of skin esterase activities from different species. Pharm. Res. 23:7 (2006), 1517–1524.
140. Rojanapo, W., Kupradinum, P., Tepsuwan, A., Chutimataewin, S., Tanyakaset, M., Carcinogenicity of an oxidation product of p-phenylenediamine. Carcinogenesis 7:12 (1986), 1997–2002.
141. Re, T.A., Mooney, D., Antignac, E., Dufour, E., Bark, I, Srinivasan, V., Nohynek, G., Application of the threshold of toxicological concern approach for the safety evaluation of calendula flower (Calendula officinalis) petals and extracts used in cosmetic and personal care products. Food Chem. Toxicol. 47 (2009), 1246–1254.
142. Renwick, A.G., Toxicology databases and the concept of thresholds of toxicological concern as used by the JECFA for the safety evaluation of flavouring agents. Toxicol. Lett. 149 (2004), 223–234.
143. Redlick, F., DeKoven, J., Allergic contact dermatitis to parapàhenylenediamine in hair dye after sensitization from black henna tattoos: a report of 6 cases. J. Can. Med. Assoc. 176:4 (2007), 445–446.
144. Rhen, L., Blasengeschwülste bei Anilinarbeitern. Archiv für klinische Chirurgie 50 (1895), 588–600.
145. Rollison, D.E., Helzlsouer, K.J., Pinney, S.M., Personal hair dye use and cancer: a systematic literature review and evaluation of exposure assessment in studies published since 1992. J. Toxicol. Environ. Health B Crit. Rev. 9:5 (2005), 413–439.
146. Ross, J.H., Dong, M.H., Krieger, R.I., Conservatism in pesticide exposure assessment. Regul. Toxicol. Pharmacol. 31 (2000), 53–88.
147. Rousseaux, C.G., Schachter, H., Regulatory issues concerning the safety, efficacy and quality of herbal remedies. Birth Defects Res. (Part B) 68 (2003), 505–510.
148. Rutkowski, J.V., Ferm, V.H., Comparison of the teratogenic effects of the isomeric forms of aminophenol in the Syrian golden hamster. Toxicol. Appl. Pharmacol. 63 (1982), 204–269.
149. Rylander, L., Axmon, A., Toren, K., Albin, M., Reproductive outcome among female hairdressers. J. Occup. Environm. Med. 59 (2002), 517–522.
150. Sardas, S., Aygün, N., Karakaya, A.E., Genotoxicity studies on professional hair colorists exposed to oxidation hair dyes. Mutation Res. 394 (1997), 153–161.
151. Sasaki, Y.F., Fujikawa, K., Ishida, K., Kawamura, N., Nishikawa, Y., Ohra, S., Satoh, M., Madarame, H., Ueno, S., Susa, S., Matsusaka, N., Tsuda, S., The alkaline single cell gel electrophoresis assay with mouse multiple organs: results with 30 aromatic amines evaluated by IARC and US NTP. Mutation Res. 440 (1999), 1–18.
152. SCC (1991). Opinion of the EU Scientific Committee of Cosmetology concerning 1,4-diaminobenzene, Colipa No. A 7, 4 October 1991.
153. SCCNFP (2002). The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers: Opinion concerning p-Phenylenediamine (Colipa A 7) adopted by the SCCNFP during the 19th plenary meeting, 27 February 2002. Available at http://europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html.
154. SCCNFP (2003). The Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. Opinion on Basioc Criteria for the In Vitri Assessment of Dermal Absorption of Cosmetic Ingredients. Adopted by the SCCNFP, 20 October, 2003. Available at: http://europa.eu.int/comm/food/fs/sc/sccp/outcome_en.html/.
155. SCCP (2006). The SCCP's notes of guidance for the testing of cosmetic ingredients and their safety evaluation. 6th Revision. 19 December 2006. Available at: http://ec.europa.eu/health/ph_risk/committees.
156. SCCP (2006a). Scientific Committee on Consumer Products. Opinion on p-Phenylenediamine, COLIPA No. A7. 10 October, 2006. Available at: http://ec.europa.eu/health/ph_risk/committees/.
157. SCCP (2009). Position statement on genotoxicity/mutagenicity testing of cosmetic ingredients without animal experiments. 21 Jnauary 2009. Available at: http://ec.europa.eu/health/ph_risk/committees/.
158. SCF, Scientific Committee for Food (1997). Opinion on The Assessment of Novel Foods: Food Science and Techniques: Reports of The Scientific Committee for Food (fortieth series). Directorate-General Industry, European Commission. Available at: http://ec.europa.eu/health/ph_risk/committees/.
159. Schaefer, H., Redelmayer, T.E. (1996). Skin Barrier. Principles of Percutaneous Absorption. 118-128 and 191-193. Eds. Schaefer H and Redelmayer TE. Karger AG, Basel, Switerland.
160. Schauer, U.M.D., Völkel, W., Heusener, A., Colnot, T., Broschard, T.H., von Landenberg, F., Dekant, W., Kinetics of 3-(4-methylbenzilidene)camphor in rats and humans after dermal application. Toxicol. Appl. Pharmacol. 216 (2006), 339–346.
161. Schilter, B., Andersson, C., Anton, R., Constable, A., Kleiner, J., O'Brien, J., Renwick, A.G., Korver, O., Smit, F., Walker, R., Guidance for the safety assesment of botanicals and botanical preparations for use in food and food supplements. Food Chem. Toxicol. 41 (2003), 1625–1649.
162. Schnuch, A., Geier, J., Uter, P.J., National rates and regional differences in sensitisation to allergens of the standard series. Contact Dermatitis 37 (1997), 200–209.
163. Schnuch, A., Lessmann, H., Frosch, P.J., Uter, W, Para-phenylenediamine: the profile of an important contact allergen. Brit. J. Dermatol. 159:2 (2008), 379–386.
164. Schnuch, A. (2009). Data presented during a recent BfR symposium on the safety of hair dyes. BfR (Federal Institute for Risk Assessment) Berlin Germany, 15 October, 2009. Summary published at the BfR web site: http://www.bfr.bund.de/cd/31861.
165. Selkirk, J.K., Soward, S.M., Abstracts from long-term cancer studies reported by the National Toxicology Program of the National Institute of Environmental Health Sciences from 1976 to 1982. Environm. Health Perspect., 101(Suppl. 1), 1993 295 pp. April 1993.
166. Shelley, W.B., Hurley, H., The allergic origin of zirconium deodorant granulomas. Brit. J. Dermatol. 70:3 (1958), 75–101.
167. Skare, J.A., Nohynek, G.J., Powrie, R., Goebel, C., Pfuhler, S., Goebel, C, Duche, D., Zeller, A., Aardema, M., Hu, T., Meuling, W.J.A., Metabolism of oxidative hair dyes: an overview of in vivo, in vitro and clinical studies. Toxicol. Lett., 172S, 2007, S31.
168. Skare, J.A., Hewitt, N.J., Doyle, E., Powrie, R., Elcombe, C. (2009). Metabolite screening of aromatic amine hair dyes using in vitro hepatic models. Xenobiotica, in print.
169. Smith, R.L., Adams, T.B., Cohen, S.M., Doull, J., Feron, V.J., Goodman, J.I., Hall, R.L., Marnett, L.J., Portoghese, P.S., Waddell, W.J., Wagner, B.M., Safety evaluation of natural flavour complexes. Toxicol Lett. 149:1-3 (2004), 197–207.
170. Smith, R.L., Cohen, S.M., Doull, J., Feron, V.J., Goodman, J.I., Marnett, L.J., Portoghese, P.S., Waddell, W.J., Wagner, B.M., Hall, R.L., Higley, N.A., Lucas-Gavin, C., Adams, T.B., A procedure for the safety evaluation of natural flavor complexes used as ingredients in food: essential oils. Food Chem. Toxicol. 43:3 (2005), 345–363.
171. Spengler, J, Bracher, M., Toxicological tests and health risk assessment of oxidative hair dye mixtures. Cosmetics and Toiletries 105:2 (1990), 67–76.
172. Stanley, L.A., Skare, J.A., Doyle, E., Powrie, R., D'Angelo, D.D., Elcombe, C.R., Lack of evidence for metabolism of p-phenylenediamine by human hepatic cytochrome P450 enzymes. Toxicology 210 (2005), 147–157.
173. Stern, S.T., McNeil, S.E., Nanotechnology safety concerns revisited. Toxicol. Sci. 101:1 (2008), 4–21.
174. Takkouche, B., Etminan, M., Montes-Martinez, A., Personal use of hair dyes and risk of cancer. A meta-analysis. J. Am. Med. Assoc. 293:20 (2005), 2516–2525.
175. TGA (2009). Therapeutic Goods Administration, Department of Health and Ageing, Australia. A review of the scientific literature on the safety of nanoparticulate titanium dioxide and zinc oxide. July 2009. Available at: http://tga.gov.au/.
176. Theogaraj, E., Riley, S., Hughes, L., Maier, M, Kirkland, D., An investigation of the photo-clastogenic potential of ultrafine titanium dioxide. Mut. Res. 634:1-2 (2007), 205–219.
177. Tregar, R.T., Dirnhuber, P., The mass of keratin removed from the stratum corneum by stripping with adhesive tape. J. Invest. Dermatol. 38 (1962), 375–381.
178. US FDA (2007). US Food and Drug Administration. Center for Food Safety and Applied Nutrition. Cosmetics. FDA Policy and Authority. Available at: http://www.cfsan.fda.gov/~dms/cos-pol.html.
179. Uter, W., Lessmann, H., Geier, J, Schnuch, A., Contact allergy to hairdressing allergens in female hairdressers and clients—current data from the IVDK 2003-2006. J. Dtsch. Dermatol. Ges. 5:11 (2007), 993–1001.
180. Verdier-Sevrain, S., Bonte, F., Skin hydration: a review of its molecular mechanism. J. Cosmet. Dermatol. 6:2 (2007), 75–82.
181. Völkel, W., Colnot, T., Schauer, U.M.D., Broschard, T.H., Dekant, W., Toxicokinetics and biotransformation of 3-(4-methylbenzilidene)camphor in rats after oral administration. Toxicol. Appl. Pharmacol. 216 (2006), 331–338.
182. WHO. Principles for the safety assessment of food additives and contaminants in food. No. 70, 1987, WHO, Geneva, Switzerland.
183. WHO, 1995. Application of the principles of substantial equivalence to the safety evaluation of foods or food components from plants derived by modern biotechnology. Report of a WHO Workshop. World Health Organisation, Geneva, Switzerland.
184. Wilkes, M.F., Woollen, B.H., Marsh, J.R., Batten, P.L., Chester, G., Biological monitoring for pesticide exposure—the role of human volunteer studies. Int. Arch. Occup. Environ. Health 65:Suppl. 1 (1993), S189–192.
185. Wilkinson, JD, Shaw, S., Skin tests. Bouillon, C., (eds.), 2nd edition The Science of Hair Care, 2005, Marcel Dekker Inc., New York and Basel.
186. Zeiger, E., Identification of rodent carcinogens and non-carcinogens using genetic toxicity tests: premises, promises and performance. Regul. Toxicol. Pharmacol. 28 (1998), 85–95.
187. Zviak, C., Millequant, J., Hair coloring. Bouillon, C., Wilkinson, J., (eds.), 2nd ed. The Science of Hair Care, 2005, Taylor and Francis, Boca Raton, Florida, US, 251–313.